Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
2(50.0%)
4Total
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05164549Phase 3Completed

Extended-release Pharmacotherapy for Opioid Use Disorder

Role: collaborator

NCT03031184Phase 3Completed

Study of Mirtazapine for Agitation in Dementia

Role: collaborator

NCT02216474Not ApplicableCompleted

Brain Stimulation in Movement Disorders

Role: lead

NCT03425110Unknown

The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults

Role: lead

NCT02410889Completed

EEG-fMRI: Towards a Useful Clinical Tool in Epilepsy

Role: collaborator

NCT02399865Not ApplicableUnknown

Family and Social Intervention for Young People

Role: collaborator

All 6 trials loaded